A business in context
JAZZ research notebook
Read the disclosures. Follow the relationships. Keep the dates in view.
Filing timeline
Download filings CSVReported insider transactions
Download transactions CSVP · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift
| Transaction / filed | Reporting owner | Type | Security | Shares | Reported price |
|---|---|---|---|---|---|
| 2026-06-15 | Smith Mark Douglas | S · Sale | Ordinary Shares | 1157.0 | 230.55 |
| 2026-06-10 | Patil Neena M | S · Sale | Ordinary Shares | 1200.0 | 231.83 |
| 2026-06-03 | GALA RENEE D | G · Gift | Ordinary Shares | 600.0 | 0.0 |
| 2026-06-01 | COZADD BRUCE C | S · Sale | Ordinary Shares | 6000.0 | 235.12 |
| 2026-05-28 | Pearce Samantha | M · Exercise / conversion | Ordinary Shares | 6907.0 | 109.45 |
| 2026-05-28 | Pearce Samantha | S · Sale | Ordinary Shares | 6907.0 | 235.41 |
| 2026-05-28 | Pearce Samantha | M · Exercise / conversion | Non-Qualified Stock Option (right to buy) | 6907.0 | 0.0 |
| 2026-05-28 | Patil Neena M | S · Sale | Ordinary Shares | 1192.0 | 236.97 |
| 2026-05-28 | Mulligan Seamus | M · Exercise / conversion | Ordinary Shares | 3415.0 | 138.08 |
| 2026-05-28 | Mulligan Seamus | M · Exercise / conversion | Non-Qualified Stock Option (right to buy) | 3415.0 | 0.0 |
| 2026-05-22 | McSharry Heather Ann | S · Sale | Ordinary Shares | 2000.0 | 241.0 |
| 2026-05-22 | Winningham Rick E | M · Exercise / conversion | Ordinary Shares | 3415.0 | 138.08 |
| 2026-05-22 | Winningham Rick E | S · Sale | Ordinary Shares | 2741.0 | 241.57 |
| 2026-05-22 | Winningham Rick E | M · Exercise / conversion | Non-Qualified Stock Option (right to buy) | 3415.0 | 0.0 |
| 2026-05-01 | COZADD BRUCE C | S · Sale | Ordinary Shares | 6000.0 | 203.33 |
| 2026-04-01 | COZADD BRUCE C | S · Sale | Ordinary Shares | 2292.0 | 190.94 |
| 2026-04-01 | COZADD BRUCE C | S · Sale | Ordinary Shares | 3684.0 | 190.22 |
| 2026-04-01 | COZADD BRUCE C | S · Sale | Ordinary Shares | 24.0 | 191.74 |
Identity & relationships
SEC issuer · 0001232524Jazz Pharmaceuticals plc
Jazz PharmaceuticalsJAZZJazz Pharmaceuticals (United States)
Search names and former names
View Wikidata identity and references ↗
- Jazz Pharmaceuticals · subsidiary · wikidata
- JAZZ · subsidiary · wikidata
- Azur · alias · wikidata
- Jazz Pharmaceuticals (United States) · subsidiary · wikidata
- Jazz Pharmaceuticals (France) · subsidiary · wikidata
- JAZZ PHARMACEUTICALS INC · former SEC name · 2003-05-12 to 2012-01-18
Revenue in constant purchasing power
| Year ended | Reported USD revenue | CPI-adjusted USD revenue |
|---|---|---|
| 2024-12-31 | $4.07B | $4.33B |
| 2023-12-31 | $3.83B | $4.20B |
| 2022-12-31 | $3.66B | $4.17B |
| 2021-12-31 | $3.09B | $3.81B |
| 2020-12-31 | $2.36B | $3.05B |
| 2019-12-31 | $2.16B | $2.82B |
| 2018-12-31 | $1.89B | $2.51B |
| 2017-12-31 | $1.62B | $2.21B |